IMVT (IMVT) Stock Price & Analysis
IMVT (IMVT) rose 0.33% to USD 39.25 as of September 8, 2026 at 05:52 UTC, according to Nexqual real-time market data.
IMVT last closed at USD 39.25; the session ranged USD 38.73–39.73 on volume of 765,742 shares. Market capitalization is —, with a 52-week range of USD 14.58–45.42 (NMS). Source: Nexqual, September 8, 2026 at 05:52 UTC.
Key Statistics (as of September 8, 2026 at 05:52 UTC)
| Price | USD 39.25 |
|---|---|
| Change | ▲ 0.33% (up) |
| Previous Close | USD 39.25 |
| Open | USD 39.25 |
| Day Range | USD 38.73 – 39.73 |
| 52-Week Range | USD 14.58 – 45.42 |
| Volume | 765,742 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (IMVT)
Nexqual's technical model rates IMVT "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:52 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37.52 (neutral) |
| vs SMA50 | Below (USD 40.44) |
| MACD | -0.07 (negative) |
From IMVT's Latest SEC 10-K Filing (filed 2026-05-20)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | USD 34.93 | ▲ 2.19% |
| PCVX | Vaxcyte, Inc. | USD 61.16 | ▼ 0.68% |
| IDYA | IDEAYA Biosciences, Inc. | USD 39.86 | ▼ 0.77% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 84.95 | ▲ 0% |
| BBIO | BridgeBio Pharma, Inc. | USD 74.84 | ▼ 2.17% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:52 UTC. This page is informational and not investment advice.